Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chasing Immune Checkpoint Inhibitors in Ovarian Cancer: Novel Combinations and Biomarker Discovery
Ilaria Colombo, Katherine Karakasis, Suku Sneha, et al.
Cancers (2023) Vol. 15, Iss. 12, pp. 3220-3220
Open Access | Times Cited: 23

Showing 23 citing articles:

Network-based drug repurposing for HPV-associated cervical cancer
Faheem Ahmed, Young Jin Yang, Anupama Samantasinghar, et al.
Computational and Structural Biotechnology Journal (2023) Vol. 21, pp. 5186-5200
Open Access | Times Cited: 18
Targeting the immune microenvironment for ovarian cancer therapy
Félix Blanc‐Durand, Lai Clemence Wei Xian, David S.P. Tan
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 16
Ovarian cancer treatment and natural killer cell-based immunotherapy
Zhongru Fan, Dongyu Han, Xin Fan, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Nanotechnology for boosting ovarian cancer immunotherapy
Prabhjot Kaur, Santosh Kumar Singh, Manoj K. Mishra, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 4
Promising new drugs and therapeutic approaches for treatment of ovarian cancer—targeting the hallmarks of cancer
Julia S. Hillmann, Nicolaì Maass, Dirk Bauerschlag, et al.
BMC Medicine (2025) Vol. 23, Iss. 1
Open Access
Investigating the role of exosomal long non-coding RNAs in drug resistance within female reproductive system cancers
Nooshafarin Shirani, N. Abdi, Matin Chehelgerdi, et al.
Frontiers in Cell and Developmental Biology (2025) Vol. 13
Open Access
Molecular Biomarkers in Borderline Ovarian Tumors: Towards Personalized Treatment and Prognostic Assessment
Stefania Drymiotou, Efthymia Theodorou, Kathrine S Rallis, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 545-545
Open Access
Chemotherapy Response Score (CRS): A comprehensive review of its prognostic and predictive value in High-Grade Serous Carcinoma (HGSC)
Gian Franco Zannoni, Giuseppe Angelico, Saveria Spadola, et al.
Gynecologic Oncology (2025) Vol. 194, pp. 1-10
Open Access
Identifying prognostic biomarkers and immune interactions in ovarian cancer associated with perfluorooctanoic acid exposure: Insights from comparative toxicogenomics and molecular docking studies
Jianing Li, Xin-Long Bian, Caixia Zhang, et al.
Ecotoxicology and Environmental Safety (2025) Vol. 291, pp. 117831-117831
Open Access
Recent advances in PLGA polymer nanocarriers for ovarian cancer therapy
Tao You, Shengmin Zhang
Frontiers in Oncology (2025) Vol. 15
Open Access
Strategies to synergize PD-1/PD-L1 targeted cancer immunotherapies to enhance antitumor responses in ovarian cancer
Lin Zhao, Xi Chen, Honghai Wu, et al.
Biochemical Pharmacology (2023) Vol. 215, pp. 115724-115724
Closed Access | Times Cited: 9
New windows of surgical opportunity for gynecological cancers in the era of targeted therapies
Inge Peters, Cláudia Marchetti, Giovanni Scambia, et al.
International Journal of Gynecological Cancer (2024) Vol. 34, Iss. 3, pp. 352-362
Open Access | Times Cited: 3
Homologous recombination proficient subtypes of high-grade serous ovarian cancer: treatment options for a poor prognosis group
Nadja Stiegeler, Dale W. Garsed, George Au‐Yeung, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Uterine Carcinosarcoma (UCS): A Literature Review and Survival Analysis from a Retrospective Cohort Study
Mauro Francesco Pio Maiorano, Gennaro Cormio, Brigida Anna Maiorano, et al.
Cancers (2024) Vol. 16, Iss. 23, pp. 3905-3905
Open Access | Times Cited: 2
Genomic Landscape of Endometrial, Ovarian, and Cervical Cancers in Japan from the Database in the Center for Cancer Genomics and Advanced Therapeutics
Qian Xi, Hidenori Kage, Miho Ogawa, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 136-136
Open Access | Times Cited: 5
Enhancing precision oncology in high-grade serous carcinoma: the emerging role of antibody-based therapies
Katrin Kleinmanns, Line Bjørge
npj Women s Health (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 1
Platinum-based chemotherapy promotes antigen presenting potential in monocytes of patients with high-grade serous ovarian carcinoma
Irina Larionova, Pavel Iamshchikov, Анна Казакова, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Prediction Model for Therapeutic Responses in Ovarian Cancer Patients using Paclitaxel-resistant Immune-related lncRNAs
Xin Li, Huiqiang Liu, Fanchen Wang, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 26, pp. 4213-4231
Open Access
Research progress of immune checkpoint inhibitors in ovarian cancer
Lingli Zhao, Yanhong Zhai, Gaoli Niu
Exploration of Immunology (2024), pp. 853-870
Open Access
Genomic landscape of endometrial, ovarian and cervical cancers in Japan from database in the Center for Cancer Genomics and Advanced Therapeutics
Qian Xi, Hidenori Kage, Miho Ogawa, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Personalization of Therapy in High-Grade Serous Tubo-Ovarian Cancer—The Possibility or the Necessity?
Jacek R. Wilczyński, Edyta Paradowska, Miłosz Wilczyński
Journal of Personalized Medicine (2023) Vol. 14, Iss. 1, pp. 49-49
Open Access | Times Cited: 1
Methodical Manipulation of the TME in Ovarian Cancer
Pamela Soberanis Pina, Amit M. Oza
Clinical Cancer Research (2023) Vol. 30, Iss. 1, pp. 12-16
Closed Access
Advancing Ovarian Cancer Treatment: The Latest Insights on PARP Inhibitors from ASCO 2023
Yves van Roon, Marcus Vetter
healthbook TIMES Oncology Hematology (2023), Iss. 18
Open Access
Page 1

Scroll to top